| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
1 company
Hively Brad is a Director at Oncology Institute, Inc.. Recent SEC Form 4 filings include 3 buys and 6 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | TOI Oncology Institute, Inc. | Director | Sell | 13,333 | $3.77 | $50,290.74 | -1.9% | -9.5% | - | |
| Aug 19, 2025 | TOI Oncology Institute, Inc. | Director | Sell | 20,221 | $4.06 | $82,097.26 | -3.1% | -1.3% | - | |
| Jun 3, 2025 | TOI Oncology Institute, Inc. | Director | Sale+OE | 1,976,137 | $2.87 | $5,672,106.03 | -60.0% | +1.6% | - | |
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Director | Buy | 9,056 | $1.04 | $9,433.64 | +1.4% | +94.2% | +156.2% | |
| Dec 2, 2024 | TOI Oncology Institute, Inc. | Director | Buy | 300,000 | $0.17 | $50,000.00 | +30.5% | +365.6% | +1803.5% | |
| Nov 17, 2023 | TOI Oncology Institute, Inc. | Director | Sale+OE | 25,000 | $2.24 | $56,000.00 | -3.5% | -22.3% | -92.2% | |
| Nov 13, 2023 | TOI Oncology Institute, Inc. | Director | Sale+OE | 47,000 | $2.52 | $118,581.00 | -6.1% | -22.0% | -88.6% |